Use of prior information for Bayesian evaluation of bridging studies

Journal of Biopharmaceutical Statistics

Volumn 17, Issue 1, 2007, Pages 109-121

  Hsiao, Chin Fu ^a   Hsu, Yu Yi ^a   Tsou, Hsiao Hui ^a   Liu, Jen Pei ^b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bayesian approach; Bridging study; Extrapolation; Similarity

Indexed keywords

ARTICLE; BAYES THEOREM; CLINICAL STUDY; DATA ANALYSIS; DATA SYNTHESIS; DRUG DOSE REGIMEN; HUMAN; INFORMATION SCIENCE; MATHEMATICAL COMPUTING; POPULATION DISTRIBUTION; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; SAFETY; SAMPLE SIZE;

ALGORITHMS; BAYES THEOREM; CLINICAL TRIALS; HUMANS; INTERNATIONALITY; MODELS, STATISTICAL; RESEARCH DESIGN; SAMPLE SIZE;

EID: 33845733170     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400601001501     Document Type: Article

References (11)

1. Chow, S. C., Shao, J., Hu, O. Y. P. (2002). Assessing sensitivity and similarity in bridging studies. Journal of Biopharmaceutical Statistics 12:385-400.
2. Hsiao, C. F., Xu, J. Z., Liu, J. P. (2003). A group sequential approach to evaluation of bridging studies. Journal of Biopharmaceutical Statistics 13:793-801.
3. Hsiao, C. F., Xu, J. Z., Liu, J. P. (2005). A two-stage design for bridging studies. Journal of Biopharmaceutical Statistics 15:75-83.
4. ICH, International Conference on Harmonisation. (1998). Tripartite guidance E5 ethnic factors in the acceptability of foreign data. The U.S. Federal Register 83:31790-31796.
5. Lawrence, J., Belisle, P. (1997). Bayesian sample size determination for normal means and differences between normal means. The Statistician 46:209-226.
6. Liu, J. P., Chow, S. C. (2002). Bridging studies for clinical development. Journal of Biopharmaceutical Statistics 12:357-369.
7. Liu, J. P., Hsiao, C. F., Hsueh, H. M. (2002). Bayesian approach to evaluation of bridging studies. Journal of Biopharmaceutical Statistics 12:401-408.
8. Liu, J. P., Hsueh, H. M., Chen, J. J. (2002). Sample size requirement for evaluation of bridging evidence. Biometrical Journal 44:969-981.
9. Liu, J. P., Hsueh, H. M., Hsiao, C. F. (2004). Bayesian non-inferior approach to evaluation of bridging studies. Journal of Biopharmaceutical Statistics 14:291-300.
10. Pettiti, D. B. (2000). Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. New York: Oxford University Press, pp. 90-129.
11. Shih, W. J. (2001). Clinical trials for drug registration in Asian-Pacific countries: proposal for a new paradigm from a statistical perspective. Controlled Clinical Trials 22:357-366.